Does BICALUTAMIDE Cause Hormone-refractory prostate cancer? 50 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Hormone-refractory prostate cancer have been filed in association with BICALUTAMIDE (Bicalutamide). This represents 1.2% of all adverse event reports for BICALUTAMIDE.
50
Reports of Hormone-refractory prostate cancer with BICALUTAMIDE
1.2%
of all BICALUTAMIDE reports
0
Deaths
3
Hospitalizations
How Dangerous Is Hormone-refractory prostate cancer From BICALUTAMIDE?
Of the 50 reports, 3 (6.0%) required hospitalization.
Is Hormone-refractory prostate cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BICALUTAMIDE. However, 50 reports have been filed with the FAERS database.
What Other Side Effects Does BICALUTAMIDE Cause?
Malignant neoplasm progression (352)
Prostatic specific antigen increased (322)
Drug ineffective (268)
Fatigue (258)
Prostate cancer (258)
Asthenia (223)
Hot flush (219)
Off label use (171)
Disease progression (169)
Anaemia (164)
What Other Drugs Cause Hormone-refractory prostate cancer?
RADIUM RA-223 DICHLORIDE (441)
LEUPROLIDE (180)
DOCETAXEL (123)
ENZALUTAMIDE (120)
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (110)
DAROLUTAMIDE (104)
ABIRATERONE (83)
PREDNISONE (58)
CABAZITAXEL (57)
CARBOPLATIN (27)
Which BICALUTAMIDE Alternatives Have Lower Hormone-refractory prostate cancer Risk?
BICALUTAMIDE vs BICTEGRAVIR
BICALUTAMIDE vs BICTEGRAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE
BICALUTAMIDE vs BIFIDOBACTERIUM LONGUM
BICALUTAMIDE vs BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS
BICALUTAMIDE vs BILASTINE